Applied Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Applied Therapeutics, Inc.‘s stocks are currently a part of 19 hedge funds’ portfolios, which represents 29.82% of the total amount of its stocks outstanding. This makes up a total of 11.27M shares of Applied Therapeutics, Inc.. Compared to the previous quarter, the number fell by -42.68% or -8.39M shares fewer. As for the holding position changes, 26.32% (5) of current hedge fund investors increased the number of shares held, 26.32% (5) of current holders sold a part of the shares held, and 10.53% (2) closed the holdings completely. 6 hedge funds are new holders of Applied Therapeutics, Inc. stock in Q1 2023, it is 31.58% of total holders.
Hedge funds holding Applied Therapeutics (Q2 2019 – Q1 2023)
| Q2 2019 | 13 |
|---|---|
| Q3 2019 | 30 |
| Q4 2019 | 45 |
| Q1 2020 | 62 |
| Q2 2020 | 72 |
| Q3 2020 | 64 |
| Q4 2020 | 65 |
| Q1 2021 | 66 |
| Q2 2021 | 67 |
| Q3 2021 | 68 |
| Q4 2021 | 66 |
| Q1 2022 | 68 |
| Q2 2022 | 46 |
| Q3 2022 | 37 |
| Q4 2022 | 36 |
| Q1 2023 | 19 |
Hedge funds changes in Applied Therapeutics positions (Q2 2019 – Q1 2023)
| Q2 2019 | 13 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2019 | 20 | 3 | 4 | 3 | 0 |
| Q4 2019 | 17 | 25 | 2 | 2 | -1 |
| Q1 2020 | 24 | 25 | 10 | 7 | -4 |
| Q2 2020 | 21 | 43 | 6 | 11 | -9 |
| Q3 2020 | 10 | 21 | 20 | 18 | -5 |
| Q4 2020 | 11 | 27 | 17 | 10 | 0 |
| Q1 2021 | 5 | 36 | 14 | 4 | 7 |
| Q2 2021 | 10 | 29 | 12 | 9 | 7 |
| Q3 2021 | 8 | 21 | 18 | 7 | 14 |
| Q4 2021 | 11 | 28 | 15 | 13 | -1 |
| Q1 2022 | 15 | 19 | 18 | 13 | 3 |
| Q2 2022 | 10 | 13 | 16 | 30 | -23 |
| Q3 2022 | 2 | 13 | 11 | 11 | 0 |
| Q4 2022 | 7 | 5 | 16 | 8 | 0 |
| Q1 2023 | 6 | 5 | 5 | 2 | 1 |
Hedge funds changes in Applied Therapeutics stock options (Q2 2019 – Q1 2023)
| Q2 2019 | 0 | 0 |
|---|---|---|
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 534,000 | 0 |
| Q4 2020 | 595,000 | 9,262,000 |
| Q1 2021 | 314,000 | 1,000 |
| Q2 2021 | 423,000 | 1,526,000 |
| Q3 2021 | 1,295,000 | 1,617,000 |
| Q4 2021 | 1,104,000 | 503,000 |
| Q1 2022 | 22,000 | 57,000 |
| Q2 2022 | 14,000 | 16,000 |
| Q3 2022 | 4,146,000 | 2,000 |
| Q4 2022 | 84,564 | 76 |
| Q1 2023 | 17,000 | 0 |